Industry News
Researchers track protein 'hitchhiker' in fluorescent worms
4/09/2015
Understanding healthy cell division could have implications for cancer patients, embryosDividing cells--whether they're in an embryo or an adult--rely on the right processes happening at the...
Can cancer vaccines prolong survival?
4/09/2015
Therapeutic anti-cancer vaccines developed to treat metastatic disease such as advanced prostate cancer or melanoma rarely have a noticeable effect on the tumor but have been associated with a...
Catheter-related bloodstream infections examined in home parenteral nutrition patients
4/09/2015
Catheter-related bloodstream infection is the most prevalent and severe complication for patients who receive parenteral nutrition therapy at home.
Common cancers hijack powerhouses of cells
4/09/2015
Discovery offers new target in up to 30 percent of cancersIn a breakthrough in the understanding of how cancer does its deadly work, researchers at the University of Virginia School of Medicine...
A third of breast cancer patients concerned about genetic risk
4/09/2015
Survey of breast cancer patients finds unmet need for discussion around genetic testingA new study from the University of Michigan Comprehensive Cancer Center finds that many women diagnosed with...
Women and men have different exclusion criteria for rtPA
4/09/2015
After analyzing stroke treatment records, researchers at Rhode Island Hospital in collaboration with researchers from the University of Cincinnati learned that women and men have different reasons...
Long-term analysis of Radiation Therapy Oncology Group (RTOG) 9903 demonstrates that the addition of erythropoietin (EPO) did not improve local-regional control for anemic patients with head and neck...
Cancer drug target also essential for blood cell recovery
4/09/2015
Blocking key 'survival' proteins is a promising tactic for treating cancer, however new research suggests care should be taken as these proteins are also vital for emergency blood cell production.
Deadly skin cancer much more common in today's seniors
4/08/2015
British people aged 65 and over are seven times more likely to develop malignant melanoma than seniors from 4 decades ago, partly due to the rise of cheap all-inclusive holidays.
Astellas Pharma Inc. and Medivation, Inc. have announced topline results from the Phase 2 STRIVE trial comparing enzalutamide with bicalutamide in a study population of men with non-metastatic or...